Form 13-F position report

PRECISION BIOSCIENCES INC

Reported by BlackRock Inc

DTIL CUSIP 74019P207 Manager CIK 0002012383

Reported 1,606,781 shares, up 433,908 (37.0%) from the prior quarter.

Reported value 9.1%; share count 37.0% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 1,606,781 Quarter-end amount reported
Reported value $10,058,448 Fair value at quarter end
Consecutive quarters held 11 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-03-31 358011
2024-06-30 514211
2024-09-30 493812
2024-12-31 210014
2025-03-31 261487
2025-06-30 241458
2025-09-30 544819
2025-12-31 700256
2026-03-31 1098687
2026-06-30 9218782
2026-09-30 10058448

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for PRECISION BIOSCIENCES INC held by BlackRock Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,606,781 +433,908 (37.0%) < 0.01% $10,058,448 2026-11-13
Q2 2026 Added 1,172,873 +973,112 (487.1%) < 0.01% $9,218,782 2026-08-07
Q1 2026 Added 199,761 +31,430 (18.7%) < 0.01% $1,098,687 2026-05-13
Q4 2025 Added 168,331 +69,632 (70.5%) < 0.01% $700,256 2026-02-12
Q3 2025 Added 98,699 +41,209 (71.7%) < 0.01% $544,819 2025-11-12
Q2 2025 Added 57,490 +2,671 (4.9%) < 0.01% $241,458 2025-08-12
Q1 2025 Reduced 54,819 -303 (-0.5%) < 0.01% $261,487 2025-05-02
Q4 2024 Added 55,122 +9 (0.0%) < 0.01% $210,014 2025-02-07
Q3 2024 New 55,113 +55,113 (0.0%) < 0.01% $493,812 2024-11-13
Q2 2024 Added 52,848 +26,446 (100.2%) < 0.01% $514,211 2024-08-13
Q1 2024 New 26,402 +26,402 (0.0%) < 0.01% $358,011 2024-05-10

Who else reported the position

114 managers reported PRECISION BIOSCIENCES INC for Q3 2026.

Managers reporting PRECISION BIOSCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Lynx1 Capital Management LP Added 2,758,215 +1,807,749 2.67% $17,266,426 8 qtrs
abrdn plc Unchanged 2,230,178 0 0.02% $13,960,914 4 qtrs
Bleichroeder LP Unchanged 2,018,190 0 1.24% $12,633,869 7 qtrs
BlackRock Inc This report Added 1,606,781 +433,908 < 0.01% $10,058,448 9 qtrs
BOOTHBAY FUND MANAGEMENT LLC Unchanged 1,346,004 0 0.14% $8,425,985 7 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 1,102,925 -13,316 < 0.01% $6,904,311 3 qtrs
DRIEHAUS CAPITAL MANAGEMENT LLC Unchanged 946,707 0 0.04% $5,926,386 4 qtrs
Parkman Healthcare Partners LLC New 836,756 +836,756 0.47% $5,238,093 1 qtr
Affinity Asset Advisors LLC Unchanged 646,576 0 0.16% $4,047,566 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 634,158 +13,177 < 0.01% $3,971,222 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
1,571,787
Shared
0
None
34,994

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.